Table of Contents
1. REPORT PROLOGUE
2. MARKET INTRODUCTION
2.1. Definition
2.2. Scope of the Study
2.2.1. Research Objective
2.2.2. Assumptions
2.2.3. Limitations
3. RESEARCH METHODOLOGY
3.1. Overview
3.2. Primary Research
3.3. Secondary Research
3.4. Market Size Estimation
4. MARKET DYNAMICS
4.1. Overview
4.2. Drivers
4.3. Restraints
4.4. Opportunities
5. MARKET FACTOR ANALYSIS
5.1. Porter’s Five Forces Analysis
5.1.1. Bargaining Power of Suppliers
5.1.2. Bargaining Power of Buyers
5.1.3. Threat of New Entrants
5.1.4. Threat of Substitutes
5.1.5. Intensity of Rivalry
5.2. Value Chain Analysis
6. GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET, BY PRODUCT
6.1. Overview
6.2. Oligonucleotide
6.2.1. Column-based oligos
Market Estimates & Forecast, by Region, 2023-2030
Market Estimates & Forecast, by Country, 2023-2030
6.2.2. Array-based oligos
Market Estimates & Forecast, by Region, 2023-2030
Market Estimates & Forecast, by Country, 2023-2030
6.3. Reagents
Market Estimates & Forecast, by Region, 2023-2030
Market Estimates & Forecast, by Country, 2023-2030
6.4. Equipment
Market Estimates & Forecast, by Region, 2023-2030
Market Estimates & Forecast, by Country, 2023-2030
7. GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET, BY TYPE
7.1. Overview
7.2. Custom Oligos
Market Estimates & Forecast, by Region, 2023-2030
Market Estimates & Forecast, by Country, 2023-2030
7.3. Predesigned Oligos
Market Estimates & Forecast, by Region, 2023-2030
Market Estimates & Forecast, by Country, 2023-2030
8. GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET, BY APPLICATION
8.1. Overview
8.2. Therapeutic Applications
8.2.1. RNAi
Market Estimates & Forecast, by Region, 2023-2030
Market Estimates & Forecast, by Country, 2023-2030
8.2.2. Nucleic Acid Aptamers
Market Estimates & Forecast, by Region, 2023-2030
Market Estimates & Forecast, by Country, 2023-2030
8.2.3. DNA/Antisense Oligonucleotides
Market Estimates & Forecast, by Region, 2023-2030
Market Estimates & Forecast, by Country, 2023-2030
8.2.4. Immunotherapy
Market Estimates & Forecast, by Region, 2023-2030
Market Estimates & Forecast, by Country, 2023-2030
8.3. Diagnostics
Market Estimates & Forecast, by Region, 2023-2030
Market Estimates & Forecast, by Country, 2023-2030
8.4. Research
8.4.1. PCR
Market Estimates & Forecast, by Region, 2023-2030
Market Estimates & Forecast, by Country, 2023-2030
8.4.1. QPCR/RTQPCR
Market Estimates & Forecast, by Region, 2023-2030
Market Estimates & Forecast, by Country, 2023-2030
8.4.1. Sequencing
Market Estimates & Forecast, by Region, 2023-2030
Market Estimates & Forecast, by Country, 2023-2030
8.4.1. Gene Synthesis
Market Estimates & Forecast, by Region, 2023-2030
Market Estimates & Forecast, by Country, 2023-2030
8.5. Others
Market Estimates & Forecast, by Region, 2023-2030
Market Estimates & Forecast, by Country, 2023-2030
9. GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET, BY END USER
9.1. Overview
9.2. Hospitals
Market Estimates & Forecast, by Region, 2023-2030
Market Estimates & Forecast, by Country, 2023-2030
9.3. Specialty Clinics
Market Estimates & Forecast, by Region, 2023-2030
Market Estimates & Forecast, by Country, 2023-2030
9.4. Research Institutes
Market Estimates & Forecast, by Region, 2023-2030
Market Estimates & Forecast, by Country, 2023-2030
9.5. Diagnostic Centers
Market Estimates & Forecast, by Region, 2023-2030
Market Estimates & Forecast, by Country, 2023-2030
9.6. Others
Market Estimates & Forecast, by Region, 2023-2030
Market Estimates & Forecast, by Country, 2023-2030
10. GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET, BY REGION
10.1. Overview
10.2. Americas
10.2.1. North America
10.2.1.1. US
10.2.1.2. Canada
10.2.2. Latin America
10.3. Europe
10.3.1. Western Europe
10.3.1.1. Germany
10.3.1.2. France
10.3.1.3. Italy
10.3.1.4. Spain
10.3.1.5. UK
10.3.1.6. Rest of Western Europe
10.3.2. Eastern Europe
10.4. Asia-Pacific
10.4.1. Japan
10.4.2. China
10.4.3. India
10.4.4. Australia
10.4.5. South Korea
10.4.6. Rest of Asia-Pacific
10.5. Middle East & Africa
10.5.1. Middle East
10.5.2. Africa
11. COMPANY LANDSCAPE
11.1. Overview
11.2. Competitive Analysis
11.3. Market Share Analysis
11.4. Major Growth Strategy in the Global Oligonucleotide Synthesis Market
11.5. Competitive Benchmarking
11.6. Leading Players in Terms of Number of Developments in the Global Oligonucleotide Synthesis Market
11.7. Key developments and Growth Strategies
11.7.1. Product Launch/Service Deployment
11.7.2. Mergers and Acquisitions
11.7.3. Joint Ventures
11.8. Major Players Financial Matrix & Market Ratio
11.8.1. Sales & Operating Income 2019
11.8.2. Major Players R&D Expenditure 2019
11.9. Major Players Capital Market Ratio
12. COMPANY PROFILES
12.1. Thermo Fisher Scientific, Inc.
12.1.1. Company Overview
12.1.2. Product Overview
12.1.3. Financial Overview
12.1.4. Key Developments
12.1.5. SWOT Analysis
12.1.6. Key Strategies
12.2. Adtbio
12.2.1. Company Overview
12.2.2. Product Overview
12.2.3. Financial Overview
12.2.4. Key Developments
12.2.5. SWOT Analysis
12.2.6. Key Strategies
12.3. Merck - Co., Inc.
12.3.1. Company Overview
12.3.2. Product Overview
12.3.3. Financial Overview
12.3.4. Key Developments
12.3.5. SWOT Analysis
12.3.6. Key Strategies
12.4. Bio-Synthesis Inc.
12.4.1. Company Overview
12.4.2. Product Overview
12.4.3. Financial Overview
12.4.4. Key Developments
12.4.5. SWOT Analysis
12.4.6. Key Strategies
12.5. Eurofins Genomics
12.5.1. Company Overview
12.5.2. Product Overview
12.5.3. Financial Overview
12.5.4. Key Developments
12.5.5. SWOT Analysis
12.5.6. Key Strategies
12.6. GE Healthcare
12.6.1. Company Overview
12.6.2. Product Overview
12.6.3. Financial Overview
12.6.4. Key Developments
12.6.5. SWOT Analysis
12.6.6. Key Strategies
12.7. Horizon Discovery Ltd
12.7.1. Company Overview
12.7.2. Product Overview
12.7.3. Financial Overview
12.7.4. Key Developments
12.7.5. SWOT Analysis
12.7.6. Key Strategies
12.8. Agilent Technologies
12.8.1. Company Overview
12.8.2. Product Overview
12.8.3. Financial Overview
12.8.4. Key Developments
12.8.5. SWOT Analysis
12.8.6. Key Strategies
12.9. Genscript
12.9.1. Company Overview
12.9.2. Product Overview
12.9.3. Financial Overview
12.9.4. Key Developments
12.9.5. SWOT Analysis
12.9.6. Key Strategies
12.10. Kaneka Eurogentec S.A.
12.10.1. Company Overview
12.10.2. Product Overview
12.10.3. Financial Overview
12.10.4. Key Developments
12.10.5. SWOT Analysis
12.10.6. Key Strategies
12.11. Nitto Denko Avecia
12.11.1. Company Overview
12.11.2. Product Overview
12.11.3. Financial Overview
12.11.4. Key Developments
12.11.5. SWOT Analysis
12.11.6. Key Strategies
12.12. Integrated DNA Technologies, Inc.
12.12.1. Company Overview
12.12.2. Product Overview
12.12.3. Financial Overview
12.12.4. Key Developments
12.12.5. SWOT Analysis
12.12.6. Key Strategies
12.13. BioAutomation
12.13.1. Company Overview
12.13.2. Product Overview
12.13.3. Financial Overview
12.13.4. Key Developments
12.13.5. SWOT Analysis
12.13.6. Key Strategies
12.14. LGC Biosearch Technologies
12.14.1. Company Overview
12.14.2. Product Overview
12.14.3. Financial Overview
12.14.4. Key Developments
12.14.5. SWOT Analysis
12.14.6. Key Strategies
12.15. Others
13. APPENDIX
13.1. References
13.2. Related Reports
LIST OF TABLES
TABLE 1 GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET SYNOPSIS, 2023-2030
TABLE 2 GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET ESTIMATES & FORECAST, 2023-2030 (USD MILLION)
TABLE 3 GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET, BY TYPE, 2023-2030 (USD MILLION)
TABLE 4 GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
TABLE 5 GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
TABLE 6 GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET, BY END USER, 2023-2030 (USD MILLION)
TABLE 7 GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET, BY REGION, 2023-2030 (USD MILLION)
TABLE 8 NORTH AMERICA: OLIGONUCLEOTIDE SYNTHESIS MARKET, BY TYPE, 2023-2030 (USD MILLION)
TABLE 9 NORTH AMERICA: OLIGONUCLEOTIDE SYNTHESIS MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
TABLE 10 NORTH AMERICA: OLIGONUCLEOTIDE SYNTHESIS MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
TABLE 11 NORTH AMERICA: OLIGONUCLEOTIDE SYNTHESIS MARKET, BY END USER, 2023-2030 (USD MILLION)
TABLE 12 US: OLIGONUCLEOTIDE SYNTHESIS MARKET, BY TYPE, 2023-2030 (USD MILLION)
TABLE 13 US: OLIGONUCLEOTIDE SYNTHESIS MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
TABLE 14 US: OLIGONUCLEOTIDE SYNTHESIS MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
TABLE 15 US: OLIGONUCLEOTIDE SYNTHESIS MARKET, BY END USER, 2023-2030 (USD MILLION)
TABLE 16 CANADA: OLIGONUCLEOTIDE SYNTHESIS MARKET, BY TYPE, 2023-2030 (USD MILLION)
TABLE 17 CANADA: OLIGONUCLEOTIDE SYNTHESIS MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
TABLE 18 CANADA: OLIGONUCLEOTIDE SYNTHESIS MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
TABLE 19 CANADA: OLIGONUCLEOTIDE SYNTHESIS MARKET, BY END USER, 2023-2030 (USD MILLION)
TABLE 20 LATIN AMERICA: OLIGONUCLEOTIDE SYNTHESIS MARKET, BY TYPE, 2023-2030 (USD MILLION)
TABLE 21 LATIN AMERICA: OLIGONUCLEOTIDE SYNTHESIS MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
TABLE 22 LATIN AMERICA: OLIGONUCLEOTIDE SYNTHESIS MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
TABLE 23 LATIN AMERICA: OLIGONUCLEOTIDE SYNTHESIS MARKET, BY END USER, 2023-2030 (USD MILLION)
TABLE 24 EUROPE: OLIGONUCLEOTIDE SYNTHESIS MARKET, BY TYPE, 2023-2030 (USD MILLION)
TABLE 25 EUROPE: OLIGONUCLEOTIDE SYNTHESIS MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
TABLE 26 EUROPE: OLIGONUCLEOTIDE SYNTHESIS MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
TABLE 27 EUROPE: OLIGONUCLEOTIDE SYNTHESIS MARKET, BY END USER, 2023-2030 (USD MILLION)
TABLE 28 WESTERN EUROPE: OLIGONUCLEOTIDE SYNTHESIS MARKET, BY TYPE, 2023-2030 (USD MILLION)
TABLE 29 WESTERN EUROPE: OLIGONUCLEOTIDE SYNTHESIS MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
TABLE 30 WESTERN EUROPE: OLIGONUCLEOTIDE SYNTHESIS MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
TABLE 31 WESTERN EUROPE: OLIGONUCLEOTIDE SYNTHESIS MARKET, BY END USER, 2023-2030 (USD MILLION)
TABLE 32 EASTERN EUROPE: OLIGONUCLEOTIDE SYNTHESIS MARKET, BY TYPE, 2023-2030 (USD MILLION)
TABLE 33 EASTERN EUROPE: OLIGONUCLEOTIDE SYNTHESIS MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
TABLE 34 EASTERN EUROPE: OLIGONUCLEOTIDE SYNTHESIS MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
TABLE 35 EASTERN EUROPE: OLIGONUCLEOTIDE SYNTHESIS MARKET, BY END USER, 2023-2030 (USD MILLION)
TABLE 36 ASIA-PACIFIC: OLIGONUCLEOTIDE SYNTHESIS MARKET, BY TYPE, 2023-2030 (USD MILLION)
TABLE 37 ASIA-PACIFIC: OLIGONUCLEOTIDE SYNTHESIS MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
TABLE 38 ASIA-PACIFIC: OLIGONUCLEOTIDE SYNTHESIS MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
TABLE 39 ASIA-PACIFIC: OLIGONUCLEOTIDE SYNTHESIS MARKET, BY END USER, 2023-2030 (USD MILLION)
TABLE 40 MIDDLE EAST & AFRICA: OLIGONUCLEOTIDE SYNTHESIS MARKET, BY TYPE, 2023-2030 (USD MILLION)
TABLE 41 MIDDLE EAST & AFRICA: OLIGONUCLEOTIDE SYNTHESIS MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
TABLE 42 MIDDLE EAST & AFRICA: OLIGONUCLEOTIDE SYNTHESIS MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
TABLE 43 MIDDLE EAST & AFRICA: OLIGONUCLEOTIDE SYNTHESIS MARKET, BY END USER, 2023-2030 (USD MILLION)
LIST OF FIGURES
FIGURE 1 RESEARCH PROCESS
FIGURE 2 MARKET STRUCTURE FOR THE GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET
FIGURE 3 MARKET DYNAMICS FOR THE GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET
FIGURE 4 GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET SHARE, BY TYPE, 2019 (%)
FIGURE 5 GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET SHARE, BY PRODUCT, 2019 (%)
FIGURE 6 GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET SHARE, BY APPLICATION, 2019 (%)
FIGURE 7 GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET SHARE, BY END USER, 2019 (%)
FIGURE 8 GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET SHARE, BY REGION, 2019 (%)
FIGURE 9 AMERICAS: OLIGONUCLEOTIDE SYNTHESIS MARKET SHARE BY REGION, 2019 (%)
FIGURE 10 NORTH AMERICA: OLIGONUCLEOTIDE SYNTHESIS MARKET SHARE, BY COUNTRY, 2019 (%)
FIGURE 11 EUROPE: OLIGONUCLEOTIDE SYNTHESIS MARKET SHARE, BY REGION, 2019 (%)
FIGURE 12 WESTERN EUROPE: OLIGONUCLEOTIDE SYNTHESIS MARKET SHARE, BY COUNTRY, 2019 (%)
FIGURE 13 ASIA-PACIFIC: OLIGONUCLEOTIDE SYNTHESIS MARKET SHARE, BY COUNTRY, 2019 (%)
FIGURE 14 MIDDLE EAST & AFRICA: OLIGONUCLEOTIDE SYNTHESIS MARKET SHARE, BY COUNTRY, 2019 (%)
FIGURE 15 GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET: COMPANY SHARE ANALYSIS, 2019 (%)
FIGURE 16 THERMO FISHER SCIENTIFIC, INC.: KEY FINANCIALS
FIGURE 17 THERMO FISHER SCIENTIFIC, INC.: SEGMENTAL REVENUE
FIGURE 18 THERMO FISHER SCIENTIFIC, INC.: REGIONAL REVENUE
FIGURE 19 ADTBIO: KEY FINANCIALS
FIGURE 20 ADTBIOV: SEGMENTAL REVENUE
FIGURE 21 ADTBIO: REGIONAL REVENUE
FIGURE 22 MERCK - CO., INC.: KEY FINANCIALS
FIGURE 23 MERCK - CO., INC.: SEGMENTAL REVENUE
FIGURE 24 MERCK - CO., INC.: REGIONAL REVENUE
FIGURE 25 BIO-SYNTHESIS INC.: KEY FINANCIALS
FIGURE 26 BIO-SYNTHESIS INC.: SEGMENTAL REVENUE
FIGURE 27 BIO-SYNTHESIS INC.: REGIONAL REVENUE
FIGURE 28 EUROFINS GENOMICS: KEY FINANCIALS
FIGURE 29 EUROFINS GENOMICS: SEGMENTAL REVENUE
FIGURE 30 EUROFINS GENOMICS: REGIONAL REVENUE
FIGURE 31 GE HEALTHCARE: KEY FINANCIALS
FIGURE 32 GE HEALTHCARE: SEGMENTAL REVENUE
FIGURE 33 GE HEALTHCARE: REGIONAL REVENUE
FIGURE 34 HORIZON DISCOVERY LTD: KEY FINANCIALS
FIGURE 35 HORIZON DISCOVERY LTD: SEGMENTAL REVENUE
FIGURE 36 HORIZON DISCOVERY LTD.: REGIONAL REVENUE
FIGURE 37 AGILENT TECHNOLOGIES: KEY FINANCIALS
FIGURE 38 AGILENT TECHNOLOGIES: SEGMENTAL REVENUE
FIGURE 39 AGILENT TECHNOLOGIES: REGIONAL REVENUE
FIGURE 40 GENSCRIPT: KEY FINANCIALS
FIGURE 41 GENSCRIPT: SEGMENTAL REVENUE
FIGURE 42 GENSCRIPT: REGIONAL REVENUE
FIGURE 43 KANEKA EUROGENTEC SA: KEY FINANCIALS
FIGURE 44 KANEKA EUROGENTEC SA: SEGMENTAL REVENUE
FIGURE 45 KANEKA EUROGENTEC SA: REGIONAL REVENUE
FIGURE 46 NITTO DENKO AVECIA: KEY FINANCIALS
FIGURE 47 NITTO DENKO AVECIA: SEGMENTAL REVENUE
FIGURE 48 NITTO DENKO AVECIA: REGIONAL REVENUE
FIGURE 49 INTEGRATED DNA TECHNOLOGIES, INC.: KEY FINANCIALS
FIGURE 50 INTEGRATED DNA TECHNOLOGIES, INC.: SEGMENTAL REVENUE
FIGURE 51 INTEGRATED DNA TECHNOLOGIES, INC.REGIONAL REVENUE
FIGURE 52 BIOAUTOMATION: KEY FINANCIALS
FIGURE 53 BIOAUTOMATION: SEGMENTAL REVENUE
FIGURE 54 BIOAUTOMATION: REGIONAL REVENUE
FIGURE 55 LGC BIOSEARCH TECHNOLOGIES:.KEY FINANCIALS
FIGURE 56 LGC BIOSEARCH TECHNOLOGIES.: SEGMENTAL REVENUE
FIGURE 57 LGC BIOSEARCH TECHNOLOGIES.: REGIONAL REVENUE
FIGURE 58 SAREPTA THERAPEUTICS:KEY FINANCIALS
FIGURE 59 SAREPTA THERAPEUTICS: SEGMENTAL REVENUE
FIGURE 60 SAREPTA THERAPEUTICS: REGIONAL REVENUE
FIGURE 61 AGILENT TECHNOLOGIES:KEY FINANCIALS
FIGURE 62 AGILENT TECHNOLOGIES: SEGMENTAL REVENUE
FIGURE 63 AGILENT TECHNOLOGIES: REGIONAL REVENUE
